NKGen Biotech, Inc. (NASDAQ:NKGNW) Short Interest Update

NKGen Biotech, Inc. (NASDAQ:NKGNW) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 15,400 shares, an increase of 805.9% from the December 31st total of 1,700 shares. Based on an average trading volume of 14,400 shares, the days-to-cover ratio is currently 1.1 days.

NKGen Biotech Price Performance

NKGen Biotech stock traded up $0.00 during midday trading on Tuesday, hitting $0.11. The company’s stock had a trading volume of 700 shares, compared to its average volume of 6,912. NKGen Biotech has a 1-year low of $0.02 and a 1-year high of $0.29. The company has a 50-day moving average price of $0.08 and a two-hundred day moving average price of $0.08.

About NKGen Biotech

NKGen Biotech, Inc operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It develops SNK01, an autologous NK cell therapy; and SNK02, an allogeneic NK cell therapy, which are in Phase 1 clinical trials.